Equity Investments
The Accelerator makes selective equity investments to support companies that are developing technologies with the potential to positively disrupt existing health solutions globally and especially at low cost in LMIC settings.
-
AI platform designing small RNAs
Eleven Therapeutic
Domain
Subdomain
Investment Status
-
AI-enabled platform for insect control
Osmo Labs
Domain
Subdomain
Investment Status
-
Breath biopsy platform for volatile detection
Domain
Subdomain
Investment Status
-
Dendritic-cell-based mRNA vaccine for infectious diseases
Transimmune
Domain
Subdomain
Investment Status
-
In vivo gene therapy for sickle cell disease
Domain
Subdomain
Investment Status
-
Inhaled mRNA-based therapeutic for respiratory infections
Domain
Subdomain
Investment Status
-
Inhaled mRNA-encoded antibodies for respiratory infections

Domain
Subdomain
Investment Status
-
Low-cost oral biologics
Domain
Subdomain
Investment Status
-
Nanobody-based platform to create novel vaccines
Domain
Subdomain
Investment Status
-
Next generation digital olfaction platform for disease detection

Domain
Subdomain
Investment Status